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Summary 
Hepatocytes and cholangiocytes self renew following liver injury. Following severe injury  
hepatocytes are increasingly senescent, whether Hepatic Progenitor Cells (HPCs) then contribute to 
liver regeneration is unclear. Here, we describe a mouse model where Mdm2 is inducibly deleted in 
over 98% of hepatocytes, causing apoptosis, necrosis and senescence with nearly all hepatocytes 
expressing p21. This results in florid HPC activation, which is necessary for survival, followed by 
complete, functional liver reconstitution. HPCs isolated from genetically normal mice, using cell 
surface markers, were highly expandable and phenotypically stable in vitro. These HPCs were 
transplanted into adult mouse livers where hepatocyte Mdm2 was repeatedly deleted, creating a 
non-competitive repopulation assay. Transplanted HPCs contributed significantly to restoration of 
liver parenchyma, regenerating hepatocytes and biliary epithelia, highlighting their in vivo lineage 
potency. HPCs are therefore a potential future alternative to hepatocyte or liver transplantation for 
liver disease. 
 
Introduction 
Liver transplantation is the only effective cure for advanced liver disease. However a global shortage 
in donor organs means many patients die waiting for suitable organs. Hepatocyte cell therapy is an 
attractive alternative to liver transplantation1, 2. Hepatocytes have a high replicative potential in 
vivo3, 4, however hepatocyte isolation is technically demanding, requires cadaveric liver donation, 
and hepatocytes cannot be expanded effectively in vitro5.  
Ductular reactions are activated in chronic liver injury and are thought to contain putative hepatic 
progenitor cells (HPCs) with the potential to regenerate hepatocytes and cholangiocytes6, 7. However, 
the significance of this regenerative pathway is unclear. Recent studies have sought to identify HPCs 
using surface markers8, 9 or in vivo lineage tracing10-13. These studies demonstrated that HPCs arise 
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within the liver, engraft the parenchyma14 and may have some differentiation capacity but did not 
regenerate significant quantities of liver parenchyma11-13. Only if HPCs have regeneration capacity, 
are expandable in vitro and transplantable would they be a potential future therapeutic target. 
Many dietary and chemical models of injury have been exploited to investigate the biology of HPCs15-
17. Experiments utilising hepatocyte lineage tracing in mice have shown in various liver injury models 
that hepatocytes regenerate themselves without any significant contribution from HPCs18, 19. This 
calls into question the nature and role of HPCs in liver injury and regeneration20. Further 
experiments in mice have shown that hepatocytes can change into a biliary ductular phenotype21, 22 
then later re-differentiate into hepatocytes23.  
In advanced human liver disease there is often widespread hepatocyte senescence i.e. an 
irreversible block to hepatocyte replication, indicated by p21 or p16 positivity. In this setting 
ductular reactions develop, however the functional role of putative HPCs in human liver disease is 
difficult to discern in the absence of lineage tracing24. The question arises as to whether mouse 
models of liver injury adequately reflect human disease. In the rat complete suppression of 
hepatocyte proliferation can be achieved using chemical toxins which provokes an extensive 
ductular/HPC response which is thought to regenerate parenchyma, although lineage tracing studies 
are required to formally prove this25. The transdifferentiation of hepatocytes into biliary ductules is 
damage dependent and negligible unless significant injury is induced26. 
To model the human (and rat) situation we have utilised a genetic means of inducing hepatocyte 
injury and senescence in adult mouse liver. We have exploited an AhCre system27 with an Mdm2loxp 28, 
which remains inactive until induced with β-napthoflavone (βNF). Following induction with βNF, Cre 
recombinase is expressed in >98% of hepatocytes where it renders Mdm2 inactive. Mdm2 is an E3 
ubiquitin-protein ligase that functions to degrade TRP53 (p53). Inactivation of Mdm2 results in 
upregulation of  p53 and induces p53 mediated hepatocyte death and senescence. This results in 
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rapid activation of HPCs throughout the liver, which proliferate, differentiate into hepatocytes, and 
completely restore architecture and function.  
A highly purified population of HPCs were isolated, using surface antigen profile and expanded in 
vitro. HPCs were transplanted in vivo in a non-competitive model of liver regeneration where they 
expand massively and differentiate, reconstituting the liver, significantly improving liver function and 
architecture.  
 
Results 
Transgenic targeted hepatocellular injury as a model of whole organ repair. 
To determine whether endogenous ductular cells give rise to hepatocytes we analysed a lineage 
tracing system using the CDE (choline deficient ethionine supplemented) diet - recovery model11 
(Supplementary figure 1a). To label biliary/ductular cells we used the Krt19CreERTLSLtdTomato mouse 
and found labelling strictly limited to ducts in the un-injured liver with zero hepatocyte labelling 
(Supplementary figure 1b).  Following CDE - recovery there was a minor degree of tracing into 
hepatocytes (Supplementary figure 1b, c), indicating that in this model the ductular–hepatocyte 
regeneration pathway is insignificant. We found minimal hepatocyte senescence (Supplementary 
figure 1b), in contrast to advanced human diseases and rat models of HPC activation where high 
levels of hepatocyte senescence occur29. To analyse liver regeneration in advanced injury we 
therefore studied a model of induced hepatocytes senescence in mouse.  
The activation and proliferation of HPCs in vivo requires both hepatocellular injury and inhibition of 
hepatocyte replication. To achieve this we utilised the AhCre transgenic line, which contains the rat 
Cyp1A1 promoter cloned upstream of Cre recombinase, we combined this line with a transgenic 
Mdm2 locus in which exons 5 and 6 are flanked with loxP sites (Mdm2flox/flox), to generate 
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AhCre+Mdm2flox/flox mice18, 19. Following βNF induction (Figure 1a) Cre recombinase is expressed in 
hepatocytes and Mdm2 is rendered inactive (ΔMdm2). 
Uninduced AhCreMdm2flox/flox mice have normal hepatic architecture and do not express detectable 
p53 protein in hepatocytes (Figure 1b).  Two days following induction, and Cre activation, with 20, 
40 or 80 mg/kg of βNF, rapid expression of p53 protein was observed in hepatocyte nuclei in a dose 
dependent manner (Figure 1 b and c); however following βNF administration to Mdm2flox/flox animals 
lacking the AhCre, we found no expression of p53 protein confirming p53 expression is a 
consequence of Cre activity and Mdm2 loss (Figure 1d). We also observed expression of p21 protein 
in hepatocytes following βNF administration (Figure 1e) but not in Cre- animals (Figure 1f). To 
validate Mdm2 recombination in this system following Cre activation, we isolated a highly purified 
population of hepatocytes and non-parenchymal cells (NPC) two days following high dose (80mg/Kg) 
βNF administration. We evaluated the presence of both exon 5 (which would be lost following Cre 
mediated recombination) and exon 3 (which would remain intact following Cre mediated 
recombination), thereby offering an internal control. In hepatocytes there was a 96.8% reduction in 
the quantity of genomic Mdm2 exon 5 following recombination, however only a 0.8% reduction in 
NPCs from the same cohort (Figure 1g, supplementary figure 2a-d) indicating the AhCre is highly 
specific in recombining ΔMdm2 in hepatocytes. 
Following βNF administration, ΔMdm2 mice developed jaundice after three days and required 
humane euthanasia by day 8 (Supplementary Table 1). Serum markers for liver injury (AST, bilirubin, 
alkaline phosphatase and ALT) were all elevated and serum albumin levels fell, signifying injury and 
impaired synthetic function of the livers of ΔMdm2 mice (Figure 1h-j, Supplementary figure 2e and 
f). This reduction in functionality is associated with hepatocyte necrosis by H&E staining which 
shows clear disruption of the hepatic architecture as well as increased positivity of lactate 
dehydrogenase staining (Figure 1k, Supplementary figure 2h). The levels of apoptosis in ΔMdm2 
mice was determined through TUNEL which was absent in uninduced AhCre+Mdm2flox/flox animals 
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however we found clear positive cells throughout the parenchyma in AhCre+Mdm2flox/flox mice which 
had received βNF (Figure 1l).  Further to this we found increased mRNA expression of the p53-
dependent apoptotic gene Bax1 (Supplementary figure 2g) throughout the 8 days time course in 
ΔMdm2 mice.  
Widespread hepatocyte injury promotes a ductular reaction 
Following βNF administration we found small cells appearing in the livers of ΔMdm2 mice that did 
not upregulate p53. We examined the ductular reaction in ΔMdm2 livers to ascertain whether HPCs 
arise in this model. In the un-induced liver, panCK is expressed throughout the biliary tree and is 
restricted to the portal tract (Figure 2a). Eight days following induction of the AhCre transgene the 
number of panCK positive  ductular reactions containing putsignificantly increases and are found 
migrating as cords throughout the liver parenchyma (Figure 2b and c, Supplementary figure 3a-c). 
Following AhCre induction the migrating cords of HPCs also express the HPC markers EpCAM and 
CD24 (Figure 2d, Supplementary figure 3d). In contrast, we found that the cell population that 
express EpCAM and CD24 are restricted to the biliary epithelium in the healthy liver (Figure 2e). We 
compared our AhCreΔMdm2 progenitor cell profile to those that are generated in the widely 
studied CDE model of liver damage and regeneration using FACS. Here we found an expansion of a 
cell population that expresses the HPC markers EpCAM, CD24, and CD133 (Figure 2f) in CDE; 
critically our AhCre ΔMdm2 HPCs express the same surface antigens at comparable levels. In line 
with this increase in HPC number we observed a significant increase in mRNA expression of HPC 
markers EpCAM, Dlk1, CK19 and Ascl2 over 8 days in the AhCre ΔMdm2 line (Figure 2g and h, 
Supplementary figure 3e and f). The extent of the ductular reaction in the ΔMdm2 was significantly 
greater than in the CDE diet (Supplementary figure 3g). In the ΔMdm2 livers Sox9 positive HPCs did 
not express CYP2D6 (Figure 2i). Furthermore, HPCs were not affected by the Cre system in response 
to the βNF induction, as they lacked upregulation of p53 (Figure 2j), and are proliferative following 
βNF administration and recombination of the Mdm2loxP locus in hepatocytes (Figure 2k). Proliferative 
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Bromodeoxiuridine (BrdU) positive HPCs were often found closely association with BrdU positive 
hepatocytes 8 days following AhCre induction, suggesting that hepatocytes arise from BrdU positive 
HPCs in this model. Importantly we also found that 2 days after induction there are no BrdU positive 
hepatocytes adjacent to BrdU positive HPCs, suggesting that proliferation of HPCs themselves does 
not lead to hepatocyte proliferation. (Supplementary figure 3h).  
Large scale hepatocyte replacement can arise from endogenous HPCs 
The AhCre+Mdm2flox/flox model results in massive hepatocyte injury, where more than 96% of 
hepatocytes upregulate p53, and activates a florid HPC response. In order to investigate how 
significant the HPC contribution is to regeneration we sought to induce the Mdm2 transgene and 
follow progenitor cells out to 6 months, to evaluate whether they can reconstitute the liver 
efficiently.  
To avoid the early mortality observed in AhCre+Mdm2flox/flox mice, we examined the long-term effects 
of Mdm2 recombination in AhCre+Mdm2flox/- mice.  AhCre+Mdm2flox/- mice had a somatic 
heterozygotic deficiency of the Mdm2 gene, however are phenotypically normal until the second 
Mdm2 allele is lost. Recombination was as efficient in the AhCre+Mdm2flox/- as in AhCre+Mdm2flox/flox 
counterparts (Supplementary Table 1).  In AhCre+Mdm2flox/- mice the onset of liver injury and clinical 
signs of acute disease, demonstrated through necrosis and apoptosis as demonstrated through H&E 
and TUNEL staining (Figure 3a and b), together with tachypnoea, hunching, prostration, and 
bilirubinuria occur between and 14 and 21 days following AhCre activation all of which are delayed 
in the Mdm2flox/- compared with the Mdm2flox/flox given the same induction regime. Concurrently HPC 
activation was more gradual than in the AhCre+Mdm2flox/flox counterparts and arose from d14 post 
Mdm2 deletion (Figure 3c). The most likely explanation for this delay is that compensatory changes 
occur in the hepatocytes that already lack one allele, when the second allele is removed the effect is 
less dramatic.  A similar effect of Mdm2 haploinsufficiency has been described in the context of 
tumour development30. Furthermore, no evidence of stable, nuclear p53 could be found in HPCs 
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arising in the AhCre+Mdm2flox/- indicating this long-term model faithfully recapitulates what we see in 
Mdm2flox/flox mice (Figure 3d and e).   
In AhCre+Mdm2flox/- mice following βNF administration, a large proportion developed liver damage 
then subsequently made full recoveries with dissipation of liver injury and the ductular reactions 
(Figure 3f) by 6 months.  As the AhCre is highly efficient in the liver we used the presence of nuclear 
p53 in hepatocytes to ascertain the HPC mediated hepatocellular regeneration. As anticipated, two 
days following βNF we found the majority of hepatocytes expressed the p53 protein (98.9%) (Figure 
4a and b). In addition to the high level of p53 in the liver, almost all hepatocytes (99.96%) express 
senescence marker p21 suggesting these cells enter either direct or indirect senescence 2 days 
following βNF (Figure 4c and d). 19 days following induction, p53 staining in hepatocytes was more 
heterogeneous, with 93.5% of hepatocytes still expressing p53 (Figure 4a and b). Six months 
following induction of Cre recombinase hepatocytes were largely p53 negative (only 0.14% of 
hepatocytes were positive).   The sequential dilution of p53 positivity from the hepatocyte 
population reflects the progressive replacement of Mdm2-negative hepatocytes from the 
parenchyma by HPC derived (Mdm2 intact, p53 low) hepatocytes.  
To confirm that this loss of p53 positivity was not due to down-regulation of p53 by other 
mechanisms we used the AhCre+Mdm2flox/- crossed onto a silenced R26RLacZ reporter. Following 
recombination LacZ expression could be detected throughout the intestine and liver.  Loss of 
reporter was seen over 6 months indicating that replacement of the recombined epithelium occurs 
from a non-recombined source (Figure 4e). Following recovery of AhCre+Mdm2flox/- mice no animals 
developed liver tumours or notable fibrosis (Figure 4f).  
 
Endogenous HPCs are absolutely required for adult liver regeneration following Mdm2 loss.  
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In our AhCre+Mdm2flox/- mouse model we wanted to evaluate the kinetics of cell replacement from 
p53 negative HPCs. Proliferating hepatocytes, positive for Ki67 were arranged in cord-like formations, 
with each cord of dividing hepatocytes being in contact with the distal tips of the ductular reaction 
(Figure 5a). This evidence, although indirect, suggested a role for HPCs in either supporting 
hepatocytes proliferation or differentiate into hepatocytes.  
Fn14 has been identified as a critical receptor for mitogenic stimulation of HPCs31-34. To confirm the 
regeneration we see in the AhCre Mdm2 system is a direct result of HPC activation and 
differentiation, and not due to a small number of hepatocytes which escape Mdm2 recombination 
we crossed the AhCre+Mdm2flox/flox mouse onto an Fn14 null (Fn14KO) background34. We induced the 
AhCre+Mdm2flox/floxFn14KO mouse and tracked the fate of these animals over 30 days (Figure 5b). In 
our AhCre+Mdm2flox/flox model where Fn14 is intact we detect up-regulation of Fn14 mRNA following 
induction with βNF over four days (Figure 5c). Following Cre induction, Fn14KOΔMdm2 animals 
demonstrated a significantly reduced survival, and all had to be euthanized within 10 days (Figure 
5d), unlike Fn14WTΔMdm2 mice in which 80% of animals survived to day 30. The induction of 
damage and repair on the background of Fn14 loss corresponded with failed ductular expansion 
(Figure 5e and f), indicating that in the AhCre+Mdm2flox/- mouse, HPCs are critical for hepatic 
regeneration. HPCs had a corresponding reduction in NFκB activity (Figure 5g), a downstream 
mediator of TWEAK-Fn14 signalling33. We treated ΔMdm2 mice (which are WT for the tweak 
receptor Fn14) throughout the onset of injury with 4 doses of intravenous TWEAK (Figure 6a). 4 days 
following activation of Cre, animals which had been given TWEAK had significantly increased 
numbers of ductular cells versus vehicle alone (Figure 6b and c). TWEAK treated ΔMdm2 mice also 
had a higher frequency of p53-negative hepatocytes adjacent to ductular cords (Figure 6d). To 
confirm the effect of TWEAK is on ducts instead of hepatocytes, we isolated hepatocytes from βNF-
induced animals and did not observe upregulation of Fn14 in hepatocytes after injury (Figure 6e).  
These data suggest that following loss of Mdm2 in hepatocytes, large scale parenchymal injury 
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prompts ductular expansion in a TWEAK/Fn14 dependent manner. This provides evidence of the 
beneficial effect of HPC to liver regeneration when hepatocyte senescence prevents normal 
hepatocyte regeneration.  
 
CD45-/CD31-/Ter119-/EpCAM+/CD24+/CD133+ marks a population of bipotent HPCs 
The AhCre+Mdm2flox/flox model demonstrates the efficacy of adult HPCs to regenerate the adult liver. 
In human disease, cells analogous to the murine HPCs arise in response to biological or chemical 
damage24, 35 (not typically genetic alteration), so to assess whether ex vivo HPCs can also significantly 
repopulate the adult liver we used a chemical model of hepatocellular disease, the murine CDE diet, 
previously employed to trace the fate of HPCs in vivo11, 16, 17. Isolation of these HPCs by FACS has 
been variable8, 36, 37, therefore we used HPC markers described in the literature, in combination, to 
identify the most potent HPC sub-population.  
The CDE diet resulted in ductular reactions arising from the terminal ducts of the portal tracts 
compared to control diet (Figure 7a and b). Within the panCK expressing ductular reactions, we 
observe a subpopulation of HPCs that express the surface markers EpCAM and CD24; whilst EpCAM 
is very specific for ductular cells, CD24 labels both HPCs and a population of hepatocytes in vivo 
(Figure 7c, Supplementary figure 3d). To exclude these CD24 positive hepatocytes, and to ascertain 
whether these CD24+/EpCAM+ cells were bona fide HPCs we used FACS to isolate multiple candidate 
HPC populations. We negatively selected for haematopoietic (CD45), endothelial (CD31) and 
erythroid (Ter119) lineages then positively selected for EpCAM, CD24 and CD133 (Figure 7d), 
thereby generating three candidate HPC populations EpCAM+/CD24-/CD133-, 
EpCAM+/CD24+/CD133- and EpCAM+/CD24+/CD133+. Besides an increase in total NPC population, 
all three populations were enriched in the NPC fraction of livers from mice fed the CDE diet 
compared to the control diet (Figure 7e). These three populations were plated at clonal density to 
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assess their colony forming potential. EpCAM+/CD24-/CD133- and EpCAM+/CD24+/CD133- 
populations formed infrequent, small colonies with mesenchymal characteristics, while the 
EpCAM+/CD24+/CD133+ population generated frequent colonies of packed epithelial cells, from 
hereon known as clonal density derived HPCs (cdHPCs) (Figure 7f and g).  
 
The defined population of HPCs can be expanded in vitro  
Over six weeks cdHPCs expand and proliferate in vitro. Historically expanding HPCs has been 
hampered by cells differentiating following replating; we therefore adapted a new method for 
passaging these cells where, rather than being passaged as a single cell suspension they are 
detached using highly diluted trypsin and lifted and replated as colonies, ensuring that cell-cell 
contact is maintained38. Using this method we found that the viability and phenotypically stability of 
passaged cdHPCs increased (Supplementary figure 4a). In our assay, only the cdHPC population can 
be expanded whilst maintaining an epithelial morphology, the other two populations failed to 
maintain any epithelial phenotype. The expanded cdHPC population can be maintained long-term in 
vitro (more than 30 passages and up to a year) and remains chromosomally stable having a normal 
karyotype (Figure 7h). The in vitro expanded cdHPCs maintained the co-expression of HPC markers 
EpCAM, CD24, and CD133 (Supplementary figure 4b). Expanded cdHPCs highly express HPCs related 
genes relative to housekeeping gene compared to hepatocytes (Supplementary figure 4c and d). 
Expanded cdHPCs maintained their HPC characteristics and were positive for a suite of markers 
(Sox9, CD44, Fn14, OPN1 and panCK) which have been used to define HPCs in vivo and the 
expression of these markers was maintained after 30 passages (Figure 7i, Supplementary figure 4e 
and f). We did not observe a significant change in the expression of most HPC related genes such as 
EpCAM, Ck19, Spp1, and Sox9, or Alb after long term passaging although Lgr5 expression increased 
(Supplementary figure 4e). After in vitro expansion, mean cell size reduced after 10 passages, 
however no significant changes in elongation assessed by cell roundness, or cell width to length ratio 
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were seen (Supplementary figure 4g). We calculated that in our in vitro expansion system each cell 
has divided around 32 times at passage 10 (Supplementary figure 4h). cdHPCs did not express 
endothelial (CD31), haematopoietic (CD45) or mesenchymal (GFAP and desmin) markers 
(Supplementary figure 5a and b). To ascertain the bipotemtiality of cdHPCs we differentiated them 
towards biliary or hepatic lineages. Following 3-D culture of cdHPCs in Matrigel we observed cells 
forming tubules, which had a branched morphology and lumen (Supplementary figure 5c) and 
expressed the activated bile duct marker MIC1C3 and the biliary transcription factor HNF1β 
(Supplementary figure 5c). For hepatocyte differentiation cdHPCs were treated with recombinant 
WNT3A which has been shown in other systems to promote hepatocyte differentiation39. Following 
rWNT3A treatment clusters of cdHPCs increased in size and became hexagonal in shape, and  
increased glycogen storage by PAS staining (Supplementary figure 5d). Murine albumin increased at 
the transcript level and as protein in the culture medium (Supplementary figure 5e, upper 
histograms). Concurrent with this up-regulation we found loss of biliary and progenitor associated 
genes Krt19, Epcam, Dlk1, Afp and upregulation in hepatocyte transcription factor Hnf1a  
(Supplementary figure 5e, lower histograms). When we reanalysed this population for EpCAM and 
CD24 we identified three populations EpCAM-CD24lo, EpCAM-CD24Hi and EpCAM+CD24Hi. To further 
refine where in cdHPCs the most potent progenitor cell resides we investigated the self-renewal 
ability of these cdHPC populations using a secondary clone assay. EpCAM-CD24lo, EpCAM-CD24Hi and 
EpCAM+CD24Hi were sorted and plated at clonal density. EpCAM+ clones were capable of generating 
colonies; however this was significantly impaired in EpCAM- cdHPCs, regardless of CD24 expression 
status (Supplementary figure 6a-c). 
To confirm the biliary/ductular origin of the cdHPCs, we isolated cdHPCs from Tamoxifen induced 
Krt19CreERTLSLtdTomato mice without liver injury , during CDE injury, and 2 weeks after CDE injury 
(Figure 7j).  The recombination efficiency of Krt19 expressing cells after Tamoxifen administration in 
the Krt19CreERTLSLTomato mice was 62% (Figure 7k). Zero Tomato expression was observed in the 
hepatocytes in any animal (Supplementary figure 1a).  Likewise the cdHPCs from Tamoxifen induced 
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Krt19CreERTLSLTomato mice without liver injury were 70% Tomato+ demonstrating their ductular origin. 
This percentage of TdTomato expressing cdHPCs remain constant before, during CDE injury, and 
after recovery from CDE injury (Figure 7l and m), arguing against a significant non- ductular 
contribution to this population. 
In vitro expanded HPCs can repopulate the liver after hepatocellular injury 
To ascertain the in vivo liver repopulating potency of cdHPCs  we performed transplantation studies 
using cdHPCs. cdHPCs were transfected with a plasmid expressing CAG-GFP and stably transfected 
clones selected (Figure 8a). 5x106 GFP-cdHPCs were transplanted intrasplenically into the 
AhCre+Mdm2flox/flox mice which had previously received low dose of βNF (10 mg/Kg) to induce 
hepatocellular injury. Following transplantation, recipient AhCre+Mdm2flox/flox mice were given 
repeated doses of βNF (20 mg/Kg) every 10 days to progressively ablate endogenous Mdm2loxP 
hepatocytes (Figure 8a and Supplementary table 1). Three months following transplantation, large 
patches of GFP+ cells were observed in the transplanted liver compared to controls (Figure 8b). GFP 
positive cells in the parenchyma were large and morphologically consistent with hepatocytes (Figure 
8c and Supplementary figure 7a). Transplanted animals had significantly improved liver histology 
with stronger glycogen staining (Figure 8d top and middle panel), less liver scarring, (Figure 8d 
bottom panel and Figure 8e) and increased serum albumin levels compared to controls (Figure 8f). 
The GFP expressing, cdHPC derived cells co-expressed the hepatocyte markers HNF4α and CYP2D6 
and were found in patches adjacent to host GFP negative hepatocytes (Figure 8g and 
Supplementary figure 7b). Small GFP positive ductular cells were seen that expressed panCK and 
SOX9 (biliary markers), indicating bi-lineage differentiation of transplanted cdHPCs in vivo (Figure 
8h). These GFP+ cells were found in both bile ducts and cords of ductular cells alongside host 
ductular cells (Supplementary figure 7b). cdHPCs hepatocytes were proliferating (Ki67+) in the 
recipient liver at 3 months following transplantation, whereas there was little proliferation in the 
14 
 
endogenous hepatocytes of AhCre+Mdm2flox/flox recipient mice. Concurrently, more senescent cells in 
the non-transplanted group were observed with p21 staining (Supplementary figure 7c). 
 
Discussion 
The liver regenerates through hepatocytes proliferation following moderate liver injury, and 
hepatocyte cell therapy is a potential alternative to liver transplantation40, 41. Liver regeneration 
following chronic or severe liver injury is less well defined. HPCs are activated during chronic liver 
disease when hepatocyte proliferation is impaired15, 42, 43; however whether these HPCs regenerate 
parenchyma is controversial11, 21, 44, 45. Using targeted deletion of Mdm2 in mouse hepatocytes, we 
have demonstrated that HPC activation is sufficient to regenerate a large proportion of the liver 
parenchyma. In our model, upon Cre activation the majority of hepatocytes (98.9%) accumulate p53, 
inducing senescence. To address the possibility that the 1.1% of unrecombined hepatocytes may 
regenerate the liver, we investigated the degree of hepatocyte senescence by p21 staining. Although 
the proportion of p53 high hepatocytes was 98.9%, almost all hepatocytes (99.96%) were p21 
positive, possibly reflecting either under-detection of p53 by immunohistochemistry or the 
occurrence of spreading senescence as previosly reported in vivo and in vitro 46, 47 48. The 
proliferation of p21 positive hepatocytes is irreversibly inhibited49 making it unlikely that p21 
positive hepatocytes contribute to regeneration here. Furthermore, proliferating hepatocytes were 
located at the distal tips of the HPC containing ductular reactions following βNF induction, 
suggesting HPCs contribute to the formation of new p21 negative hepatocytes that are capable of 
proliferation.  
To further investigate the importance of HPC activation, we used a model deficient in Fn14, a 
receptor for the HPC mitogen TWEAK33, 34. Mice with Fn14 knockout do not mount an appropriate 
ductular reaction, and have increased mortality. Administration of TWEAK enhanced the ductular 
15 
 
reaction in AhCre+Mdm2flox/flox mice following liver injury. These findings suggest that TWEAK/Fn14 
mediated ductular reaction are required to adequately regenerate liver parenchyma following such 
damage.  
Huch and colleagues have shown that EpCAM+ cells isolated from human liver can be expanded as 
organoids in vitro50. Whether these cells can regenerate large amounts of liver parenchyma will be 
important for their development as a human cell therapy. Here, we demonstrate that large scale 
therapeutic liver repopulation can be achieved by transplanted HPCs.  
CD45-/CD31-/Ter119-/EpCAM+/CD24+/CD133+ HPCs have high colony forming capacity and are of 
biliary origin. Using the the Krt19CreERTLSLTdTomato lineage tracing model we found the degree of 
hepatocyte formation from ductular cells in the CDE diet and recovery model is limited13, 21, 45; we 
speculate that this is due to the mild liver injury and lack of hepatocyte senescence, compared to 
advanced human liver disease51. This lack of hepatocyte senescence in the CDE model thereby 
allowing hepatocytes to regenerate themselves without recourse to a second tier of regeneration.  
Although previous studies have isolated putative HPCs using FACS isolation, these techniques are 
based on single selection markers37,8 or did not completely exclude other NPC populations37,52. We 
investigated multiple potential HPC populations by using a highly stringent FACS gating strategy 
without the need of transgenic reporter. This is important as HPCs share markers with 
cholangiocytes and a defined selection strategy is required to reduce impurity if this is going to be 
translated into human studies. We have overcome the difficulty in expanding HPCs in vitro in 
monolayer conditions whilst maintaining their karyotypic and phenotypic stability. The CD45-/CD31-
/Ter119-/EpCAM+/CD24+/CD133+ HPC population is extremely rare in healthy liver, making their 
isolation from healthy tissue logistically challenging. Furthermore, the liver repopulating capacity of 
these cells in a healthy liver is likely insignificant- previous lineage tracing studies have  shown no 
contribution from HPCs to hepatocytes in healthy liver11,44 and hepatocytes are the primary source 
of regeneration in normal liver homeostasis3. Together our data suggests the existence of a 
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facultative and functionally significant HPC population which does not contribute to homeostatic 
repair, but is activated in severe liver injury where hepatocyte senescence is widespread. We have 
used the term HPC throughout given the data confirming genuine progenitor characteristics of these 
cells within the ductular reaction, however in the absence of this functional evidence the term 
ductular cell may be more accurate.   
To date the repopulation capacity of transplanted HPCs has been limited and their ability to improve 
the structure of chronically damaged liver unproven. Using repeated rounds of hepatocyte 
senescence and injury in the AhCre+Mdm2flox/flox mice combined wih HPC transplantation we found 
that the progeny of the transplanted HPCs can proliferate long-term and regenerate large areas of 
normal parenchyma. The transplanted HPCs demonstrated bi-lineage differentiation into large 
numbers of hepatocytes and cholangiocytes in vivo causing significant structural and functional 
improvement of the damaged liver, with reducced scarring and increase serum albumin in transplant 
recipients. Our characterisation of a defined population of HPCs indicates their biological significance 
and future therapeutic potential for the treatment of human liver disease.  
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Figure 1 - Induction of hepatocyte damage following AhCre mediated loss of Mdm2. 
(a) Schematic representation of the AhCreMdm2flox/flox time course used in this study. (b) 
Immunohistochemistry for p53 mice not induced with βNF (b-c) Immunohistochemistry for p53 in 
induced AhCre+Mdm2flox/flox mice with a 20, 40 and 80mg/Kg dose of βNF, Black arrows denote p53 
negative cells. (d) low power photomicrograph of p53 staining in the AhCre-Mdm2flox/flox control. (e) 
Immunohistochemistry for p21 in induced AhCre+Mdm2flox/flox mice with 80mg/Kg dose of βNF. (f) 
low power photomicrograph of p21 staining in the AhCre-Mdm2flox/flox control. (g) Genomic PCR of 
Mdm2 exon 5/ exon 3 in hepatocytes and Non-parenchymal cells (NPCs) from ΔMdm2 versus control; 
n = 3 biological replicates. (h-j) Serum AST, bilirubin and albumin levels over the time course in 
ΔMdm2 mice compared to AhCre-, Mdm2WT/WT and uninduced controls (mean ± s.e.m , (h) P = 0.042 
(i) P = 0.046 (j) P = 0.026 one-way ANOVA; n = 3 mice each group, except day 8 in which n = 1 due to 
mortality). (k) H&E staining for ΔMdm2 following induction with 80mg/Kg βNF. (l) Apoptosis 
identified by TUNEL staining in ΔMdm2 mice following induction with 80mg/Kg βNF. White arrows 
show TUNEL positive hepatocytes. The representative images shown here are representative for 3 
experiments with 3-5 mice each group per experiments.  Data are represented as mean ± s.e.m. 
Scale bars = 50µm. 
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Figure 2 - Hepatocyte Mdm2 loss results in rapid activation of HPCs  
(a) Immunohistochemistry for HPCs (panCK, brown) in un-induced AhCre+Mdm2flox/flox mice. (b) 
Immunohistochemistry for HPCs (panCK, brown) in ΔMdm2 mice 8 days following induction with 
βNF. (c) Quantification of mean number of panCK+ cells per field over the 8 day time course 
following induction with βNF. (mean ± s.e.m, Kruskal Wallis test.  P = 0.0016;  n = 7,3,3,4,5 mice for 
days 0,2,3,5,8 respectively). (d) Immunohistochemistry for EpCAM+ CD24+ HPCs (EpCAM, green; 
CD24, red) in ΔMdm2 mice 8 days following induction with βNF. White arrows show EpCAM+ CD24+ 
HPCs (e) Immunohistochemistry for EpCAM+ CD24+ HPCs (EpCAM, green; CD24, red) in un-induced 
AhCre+Mdm2flox/flox mice. (f) FACS analysis of EPCAM+ CD24+ CD133+ HPCs in both 12 days CDE 
treated mice and βNF induced AhCre+Mdm2flox/flox mice. (g - h) mRNA expression of EpCAM and Dlk1 
over the experimental time course following induction with βNF. (mean ± s.e.m, (g) P = 0.024 on day 
6, P = 0.036 on day 8 (h) P = 0.036 on day 8, One-way ANOVA with Bonferroni correction; n = 3,3,6,5 
and 3,3,3,3 mice for days 2,3,5,8 for experimental and controls respectively). (i) 
Immunohistochemistry of 4 days post ΔMdm2 showing hepatocytes, CYP2D6 (red) and HPCs, Sox9 
(green). (j) Immunohistochemistry of day 8 ΔMdm2 showing hepatocytes (CYP2D6, blue), HPCs (Sox9, 
red) and p53 (green). White arrows CYP2D6+, p53+ hepatocytes. Yellow arrow Sox9+ HPCs adjacent 
to hepatocytes. (k) Immunohistochemistry of HPC proliferation, HPCs  (panCK, green) and 
proliferation (BrdU, red). Arrows mark BrdU labelled HPCs. BrdU labelled hepatocytes are associated 
with HPCs. The representative images shown here are representative for 2 experiments with 3-5 
mice each group per experiments.  Scale bars = 50µm 
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Figure 3 - Mdm2 deletion in Mdm2flox/- model leads to HPC expansion and subsequent recovery 
(a) H&E staining of AhCre+Mdm2flox/- 19 days following βNF administration. (b) Apoptosis stained for 
by TUNEL in AhCre+Mdm2flox/- 14 and 19 days following βNF administration. (c) HPCs (panCK) in 
AhCre+Mdm2flox/- 14 and 19 days following βNF administration (inset, higher magnification). (d) 
Immunohistochemistry for HPCs (Sox9, red), hepatocytes (CYP2D6, blue) and p53 (green). White 
arrows denote HPCs, open arrows p53 high hepatocytes and arrowheads p53 low hepatocytes. (e) 
Immunohistochemistry of HPCs (PanCK, green), p53 (red) and DNA (DAPI, blue). White arrows show 
p53 low PanCK+ HPCs. Red arrows denote p53 high hepatocytes. (f) H&E and immunohistochemistry 
for HPCs (panCK) 6 months following ΔMdm2 in the AhCre+Mdm2flox/-. The representative images 
shown here are representative for 2 experiments with 3-5 mice each group per experiment.    Scale 
bars = 50µm.  
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Figure 4 – Loss of recombined ΔMdm2 hepatocytes over time during recovery. 
 (a) Immunohistochemistry for hepatocytes (CYP2D6, red), p53 (green) and DNA (DAPI, blue) in 
AhCre+Mdm2flox/-mice 2 days, 19 days and 6 months following βNF induction. White arrow denotes 
p53 low hepatocyte.  (b) Quantification of p53 high, CYP2D6 positive hepatocytes 2 days, 19 days 
and 6 months following βNF induction (mean ± s.e.m, n = 9,5 and 11 mice for day 2, 19 and 5-9 
months respectively). (c) p21 (red), CYP2D6 (green), DAPI (blue) immunohistochemistry (top panel), 
p21 iummunohistochemistry on AhCre+Mdm2flox/- mice 2 days following βNF induction compared to 
control  (bottom panel). (d) Quantification of p21 expressing hepatocytes (bottom panel) on 
AhCre+Mdm2flox/-  mice 2 days following βNF induction compared to control (mean ± s.e.m. n = 20 
fields at x200 magnification for each biological sample quantified, n = 3 mice per group). (e) Whole 
mount X-gal staining of intestine and liver from AhCre+Mdm2flox/-mice 2 days following ΔMdM2 mice 
and 6 months following ΔMdm2. Scale bars = 1cm (f) PicroSirius red (fibrillar collagen) staining in 
ΔMdm2 livers 6 months following induction. The representative images shown here are 
representative for 3-5 mice each group per experiment. Scale bars = 50µm. 
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Figure 5 - Fn14/TWEAK regulated HPCs are necessary for liver regeneration following hepatocyte 
Mdm2 deletion.  
(a) Immunohistochemistry for proliferation (Ki67) demarcated in white and HPCs (panCK) 
demarcated in red 19 days following ΔMdm2 in AhCreMdm2flox/-. (b) Schematic representing the 
experimental time course using the Fn14KO AhCreMdM2flox/flox. (c) mRNA expression of Fn14 
following ΔMdm2 induction in AhCre+Mdm2flox/flox (mean ± s.e.m, One-way ANOVA with Bonferroni 
correction.  P = 0.05;  n = 3 mice). (d) Kaplan–Meier survival curve of ΔMdm2 control versus 
Fn14KOΔMdm2 (Mantel-Cox test P = 0.0002, n = 7 mice each group).  (e) Quantification of number of 
panCK+ HPCs in ΔMdm2 control versus Fn14KO ΔMdm2, dotted line denotes baseline HPC number in 
a WT uninjured liver (mean ± s.e.m, Mann Whitney test.  P = 0.029;  n = 3 vs. 4 mice). (f) 
Representative images of panCK+ and Sox9+ HPCs (insets high power) in the Fn14KO AhCre+ 
Mdm2flox/flox model with Fn14+ AhCre+ Mdm2flox/flox controls 4 days following 80 mg/kg βNF 
administration. (g) Active form nuclear NFκB p65 expressing panCK+ HPCs observed in Fn14+ mice 
(arrows) but not in HPCs from Fn14KO mice (arrowheads).  Sox9+/CYP2D6+ co-staining association of 
Sox9+/CYP2D6low HPCs (open-arrows) with Sox9+/CYP2D6intermediate cells with intermediate 
morphology (arrowheads) and Sox9+/CYP2D6+ hepatocytes (arrows) in each experimental group. The 
representative images shown here are representative for 3-7 mice each group per experiment.  Scale 
bars = 50 µm.  
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Figure 6 – TWEAK enhances ductular reaction through activation of HPCs 
 (a) Schematic representing the experimental time course using the AhCreMdm2flox/flox mice that 
receive intravenous injection of TWEAK. (b) Quantification of number of panCK+ HPCs in ΔMdm2 
control versus ΔMdm2 given recombinant TWEAK (mean ± s.e.m, Mann Whitney test.  P = 0.029;  n 
= 3-4 mice per group). (c) panCK staining in ΔMdm2 control mice versus ΔMdm2 mice given 
recombinant TWEAK. (d) p53 immunohistochemistry and analysis of portal tracts of both ΔMdm2 
controls and mice treated with repeated injection of i.v. TWEAK, shows p53- cells with hepatocyte 
like morphology adjacent to portal tracts and areas of ductular expansion 4 days following induction 
(80mg/kg βNF). Arrows show p53- HPCs and arrowheads show p53- hepatocytes. (e) mRNA 
expression of Fn14 from isolated HPCs and, hepatocytes isolated from wild type mice, and 
hepatocytes isolated from ΔMdm2 mice (mean ± s.e.m, One-way ANOVA.  P = 0.0129;  n = 3 mice). 
The representative images shown here are representative for 3-4 mice. Scale bars = 50µm. 
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Figure 7 - In vitro expanded HPCs are genetically and phenotypically stable.  
(a) Immunohistochemistry for HPCs (panCK) in uninjured liver and (b) mice treated with 12 days CDE 
diet. (c) Immunohistochemistry on serial sections for HPCs (panCK) and EpCAM (green), CD24 (red) 
and DAPI (blue). Arrows show EpCAM+ CD24+ HPCs. (d) FACS gating strategy to isolate 7AAD-/CD31-
/CD45-/Ter119-/EpCAM+/CD24+/CD133+ HPCs from uninjured and CDE injured liver. The data 
shown here are representative images for 10 mice (e) Histogram representing the percentage 
representation of EpCAM+ CD24- CDE133- , EpCAM+ CD24+ CD133- and EpCAM+ CD24+ CD133+ in 
the NPC fraction of healthy or CDE treated livers (mean ± s.e.m, Mann-Whitney test.  P = 0.0025;  n = 
4 mice each group). (f) Colony forming efficiency of EpCAM+ CD24- CDE133-, EpCAM+ CD24+ CD133- 
and EpCAM+ CD24+ CD133+ populations in vitro (mean ± s.e.m, One-way ANOVA.  P = 0.032, and 
0.002 respectively; n = 5 biological replicates per group).These data are representative of 3 
individual experiments (g) Phase contrast images of the colonies formed by the EpCAM+ CD24- 
CD133-, EpCAM+ CD24+ CD133- and EpCAM+ CD24+ CD133+ populations. (h) Frequency of 
chromosome number in metaphase spreads from in vitro expanded HPCs, inset, a representative 
example of a normal karyotype from in vitro expanded cdHPCs. (i) Immunocytochemistry of HPC 
markers in in vitro expanded HPCs. (j) Schematic representation of the experiment to determine the 
origin of cdHPC. (k) Immunohistochemistry on healthy, tamoxifen induced Krt19CreERTLSLTdTomato mice 
for recombined HPC, CK19 (green), TdTomato (red), and DAPI (blue). (l) Percentage of EpCAM+ 
CD24+ CD133+ population expressing TdTomato in uninjured Krt19CreERTLSLTdTomato mice, 
Krt19CreERTLSLTdTomato mice treated with CDE diet, Krt19CreERTLSLTdTomato mice treated with CDE diet 
followed by 14 days of normal diet (mean ± s.e.m, One-way ANOVA. P >0.05;  n  = 5 mice). (m) 
Merged phase contrast and fluorescent image of isolated EpCAM+CD24+CD133+TdTomato+ cells 
from Krt19CreERTLSLTdTomato mice receiving CDE diet. Data are represented as mean ± s.e.m. n = ≥3 each 
group. in vitro data represents three independent experiments. Scale bars = 50µm. 
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Figure 8 - Relationship between activated HPCs and hepatocytes 
(a)  A schematic representation of the AhCre+Mdm2flox/flox as a transplant recipient model of GFP 
expressing HPCs. Expanded HPCs stably transfected with a CAG-GFP expressing vector, left 
photomicrograph phase contrast, right GFP. (b) Low power epifluorescence of sham transplanted 
liver, ubiquitous CAG-GFP expressing liver and ΔMdm2 liver with CAG-GFP expressing transplanted 
in vitro expanded HPCs. (c) Immunohistochemistry for GFP in non-transplanted ΔMdm2 controls 
versus ΔMdm2 transplanted with CAG-GFP expressing HPCs. Black arrows denote GFP expressing 
hepatocytes and red arrow GFP expressing duct. Dot-plot shows quantification of GFP in 
transplanted versus non-transplanted liver (mean ± s.d, Student’s t-Test. P = 0,0019; n = 17 fields at 
x200 magnification). (d) Histochemical analysis of non-transplanted AhCre+Mdm2flox/flox mice and 
cdHPC transplanted AhCre+Mdm2flox/flox mice. Hematoxylin and eosin (top panel), Periodic acid – 
Schiff (middle panel), PicroSirius Red (bottom panel) . (e) PicroSirius Red area of non-transplanted 
AhCre+Mdm2flox/flox mice and cdHPC transplanted AhCre+Mdm2flox/flox mice (mean ± s.d,  Mann-
Whitney test.  P = 0.0379; n = 8 mice each group). (f) Serum Albumin level of non-transplanted 
AhCre+Mdm2flox/flox mice and cdHPC transplanted AhCre+Mdm2flox/flox mice (mean ± s.d,  Mann-
Whitney test.  P = 0.0341; n = 10 and 13 mice for non-transplanted group and transplanted group 
respectively). (g) Immunohistochemistry for GFP (green), hepatocytes (HNF4α or CYP2D6, red) and 
DNA (blue) in CAG-GFP HPC transplanted livers versus non-transplanted controls. (h) 
Immunohistochemistry for GFP (green), HPCs (panCK or Sox9, red) and DNA (blue) in non-
transplanted controls versus CAG-GFP HPC transplanted animals. Data are represented as mean ± s.d. 
The data shown are representative of 3 different experiments with 8-10 mice each group. Scale bars 
= 50µm.  








Materials and Methods 
Animal Models 
Animals used in this study were all on a C57Bl/6 background aged within 8 to 12 weeks old at the 
start of the experiments, both male and female mice were used. Animals were housed in a specific 
pathogen free environment and kept under standard conditions with a 12 hour day/night cycle and 
access to food and water ad libitum.  All animal experiments were carried out under procedural 
guidelines, severity protocols and with ethical permission from the Animal Welfare and Ethical 
Review Body (AWERB) and the Home Office (UK). Power calculations were not routinely performed, 
however animal numbers were chosen to reflect the expected magnitude of response taking into 
account the variability observed in previous experiments. AhCre+ mice were crossed with both 
Mdm2flox/flox, Mdm2flox/-  and Mdm2flox/+ mice to generate AhCre+ Mdm2flox/flox, AhCre+ Mdm2flox/- mice 
and AhCre- Mdm2flox/flox and AhCre+ Mdm2flox/+ controls.  AhCre+ Mdm2flox/flox or Mdm2+/+ mice were 
also crossed with Fn14KO (provided by Biogen Idec34). Genotyping was performed for AhCre using 
CCTGACTAGCATGGCGATAC (forward) and ATTGCCCCTGTTTCACTATC (reverse) primers and Mdm2 as 
previously described 28.  AhCre was induced by intra-peritoneal (i.p.) injection of β-Napthoflavone 
(βNF, Sigma UK) at 20-80mg/kg, prepared previously under sterile conditions at 1% (w:v) in corn oil. 
K19Cre was induced by 3 individual i.p. injections of Tamoxifen (20mg/ml, Sigma UK) at the dose of 
4mg. K19Cre animals received three weeks of normal diet after the last Tamoxifen injection before 
commencing the CDE diet regime. 
BrdU (50 μg/g, Amersham, UK) was administered by i.p. injection. Choline Deficient Ethionine 
supplemented (CDE) protocols were as previously described6,31 .  Recombinant murine TWEAK (R and 
D Systems) was delivered iv at 0.4µg on days -5,-3,-1 and 1 in sterile PBS as previously described32.  
Mice were sacrificed according to UK Home Office regulations.  Unless livers were perfused, blood 
was harvested by cardiac puncture.  Organs were harvested and stored following fixation in 10% 
formalin (in PBS) for 6hrs or methacarn (60% methanol 30% chloroform 10% glacial acetic acid) for 
24hrs prior to embedding in paraffin blocks.  Samples of liver were taken and snap frozen in an 
ethanol bath in dry ice in OCT media, RNAlater or directly for later analysis.  Serum analysis used 
commercial kits according to manufacturer’s instructions for Alanine transaminase (ALT; Alpha 
Laboratories Ltd, UK), microalbumin (Olympus Diagnostics Lt, UK), Aspartate Aminotransferase (AST) 
and Alkaline Phosphatase (Alk Phos; both Randox Laboratories, UK).  
Hepatocyte purification  
Ex vivo primary cells were isolated using a modified retrograde perfusion technique53 consisting of: 
1) Liver Perfusion Medium (Gibco) for 5 minutes; 2) Liver Digest Medium (Gibco) for 10 minutes.  
The liver was then excised and the capsule disrupted to yield a cell suspension which was collected 
in Liver Perfusion Medium (Gibco) and passed through a 100μm filter (BD Bioscences).  Hepatocytes 
were pelleted by centrifugation at 135G for 1 minute separated them from a non-parenchymal cell 
(NPC) rich fraction and each resuspended in Williams E Medium (Gibco) with 5% FCS.  The 
hepatocyte rich cell suspension was then purified as described previously53.  Briefly cells were 
underlayered with a discontinuous Percoll gradient (1.06, 1.08 and 1.12g/ml Percoll in PBS).  Cells 
were then spun at 750 G for 20 minutes at 20°C.  The cell layer collected between the 1.08 and 
1.12mg/ml Percoll layers were harvested and resuspended in Williams Medium.  Cells were then 
purified a further 2 times using Percoll layers as previously and quantified prior to analysis.  
Routinely cells with hepatocyte morphology and expression of CYP2D6 (marker of hepatocellular 
differentiation) were obtained at over 99% purity (See Supplementary Fig 2, p<0.05). 
HPC isolation 
NPCs were retained from the supernatant following the initial 135G centrifugation step.  Following 
red cell lysis (3 minutes in 160mM NH4Cl 10mM KHCO3 containing 0.01% EDTA), cells were re-
suspended in Williams E Medium (Gibco) with 10% FCS and underlayered with an equal volume of 
20% and 50% (v/v) Percoll (Sigma, UK) in PBS, respectively.  Following centrifugation at 1400g for 20 
minutes at 4°C, the HPC rich fraction lying between the 20% and 50% Percoll layers (enriched for 
non-parenchymal cells) was collected, washed twice and re-suspended in PBS with 2% FCS for FACS 
staining procedure. NPCs collected as described above were resuspended in PBS + 2% FCS prior to 
incubation with anti-mouse CD16/32 antibody (eBiosciences) for 10 minutes. After a wash with cold 
PBS, cells were resuspended in PBS + 2% FCS and were incubated with EpCAM-APC conjugated 
antibody (eBiosciences); CD24-PeCy7 conjugated antibody; CD133-FITC conjugated antibody CD45-
PE conjugated antibody; CD31-PE conjugated; Ter119-PE conjugated antibody (Biolegend). Labelled 
cells were washed with PBS containing 2% FCS and analysed by FACS using a FACS-Aria II (BD) with 
488nm and 640nm lasers using a 100 µm nozzle.  Hematopoeitic cells (CD45+), erythroid cells 
(Ter119), and endothelial cells (CD31+) were excluded by gating. 10 µg/ml 7-Aminoactinomycin D (7-
AAD) (Biolegend) was added immediately prior to sorting to exclude dead cells. Cells were analysed 
and sorted with FACS Aria II (BD).  Trigger pulse width was used to exclude cell doublets from 
analysis and collection. Sorted cells were plated on rat tail collagen 1 (Sigma) coated plates 
supplemented with previously published HPC expansion medium 8. A step-by-step protocol 
describing the isolation and expansion of HPCs can be found at Nature Protocol Exchange 
(http://dx.doi.org/10.1038/protex.2015.051)54.  
Colony forming assay 
Cells were plated at clonal density (250 cells/cm2) on collagen coated plates with culture medium. 
The number of colonies comprised of more than 50 cells was counted two weeks after plating. 
Number of colonies formed / number of wells plated = Colony Forming Efficiency.  
Expansion of HPCs 
Sorted HPCs were cultured in HPC Expansion Medium: Williams’ Medium E (Gibco) containing 10% 
FCS, 17.6mM NaHCO3, 20mM HEPES pH7.5, 10mM Nicotinamide, 1mM Sodium Pyruvate, 1x Insulin, 
Transferrin, Selenium Solution (ITS) (Gibco), 100nM Dexamethasone, 0.2mM Ascorbic Acid, 14mM 
Glucose, 10ng/mL IL-6 (Peprotech), 10ng/mL HGF (Peprotech), 10ng/mL EGF (Sigma-Aldrich).   
Cultured HPCs were washed with PBS. Cells were then incubated with diluted trypsin (0.25% Trypsin 
no EDTA, 20% Knockout Serum Replacement, 1mM CaCl2) at 37°C. Williams Medium E supplemented 
with 10% FCS were used to inhibit the reaction of trypsin. Cells were centrifuged at 300G for 5 
minutes, supernatant was then discarded. Cells were resuspened in culture medium and replated on 
collagen coated plates. 
Flow Cytometry analysis 
Cells were rinsed with PBS and then incubated with Cell Dissociation Medium (GIBCO) for 20 minutes 
at 37°C to prevent excessive cleavage of desired epitopes for detection. Cells were then incubated 
with anti-mouse CD16/32 antibody (eBiosciences) at 1:50 dilution for 10 minutes on ice. After rinsing 
with PBS, cells were resuspened in PBS + 2% FCS and incubated with antibodies (indicated in List of 
Antibodies Table) for 1 hour at 4°C. Cells were then washed with PBS + 2% FCS and then resuspened 
for in PBS + 2% FCS for analysis or sorting. Stained samples were compared to unstained and isotype 
controls.   
Immunohistochemistry 
Three μm thick paraffin sections were stained for the published HPC markers: panCK, A6 kindly 
provided by Dr V. Factor (National Cancer Institute, Bethesda, MD), Sox9, CD24,  Dlk1, EpCAM, and 
Fn14 or for the alternate antigens: BrdU, (AB6326 Abcam, UK), p53 (MS 104-P1, LabVision), Ki67, 
and CYP2D6 (Generous gift from Prof R Wolfe, University of Dundee); see Supplementary Table 2 for 
additional details.  Cytospins and cells were fixed in cold methanol at 4°C for 5 minutes prior to 
staining Species isotype (Santa Cruz) staining controls were routinely performed.  Detection was 
performed with DAB (DAKO) followed by counterstaining with Haematoxylin or alternately with 
Alexa 488, 555 or 650 (A21206, A21434A21436/S32355, and A21448 respectively; Invitrogen, UK) 
with a DAPI containing Vectasheld mounting media (Vector, UK).  Apoptosis was assessed using the 
DeadEnd™ Colorimetric or Fluorometric (Alexa 488) TUNEL System (Promega #TB199) according to 
manufacturer's instructions. 
Microscopy and cell counting 
Images were obtained on a Zeiss Axiovert 200 microscope using a Zeiss Axiocam MR camera.  Cell 
counts were performed manually on blinded slides and more than 20 consecutive non overlapping 
fields at x200 or x400 magnification.  HPCs were defined as previously described and interlobular 
bile ducts were excluded from quantification32.  Confocal image analysis was performed using a Leica 
SP5 system with the pinhole set to 1 airy unit.  DAPI, Alexafluor 488, and 555 were detected using 
band paths of 415-480, 495-540 and 561-682nm for 405, 488 543 nm lasers respectively.   
Cell Transplantation Assay 
AhCre Mdm2flox/flox mice were used as recipients for transplantation assay. 10mg/kg of βNF was 
injected i.p. 4 days before transplant to induce liver injury, 5x10 GFP expressing cells were 
suspended in 200µL of PBS and injected intrasplenically after laparotomy. Transplantation control 
group receive 200µL PBS only. Recipient mice received intraperitoneal injections of 20mg/kg βNF 
every 10 days after transplantation to induce persistent liver injury. Mice were sacrificed and the 
liver was harvested 12 weeks after cell transplantation. 
In Vitro Differentiation of Hepatic Progenitor Cells (HPCs) 
100ng/mL of Murine Recombinant Wnt3a (R&D systems) and 1% of Dimethyl Sulfoxide (DMSO) were 
added to HPCs in combination with culture medium when cultured HPCs were 70% confluent. 
Differentiation process lasted for 6 days; medium was changed once in 3 days. Medium was kept for 
ELISA and cells were lysed for RNA isolation. 
 
 
Formation of progenitor cell spheroids 
HPCs were trypsinised into a single cell suspension by incubating with Cell Dissociation Medium 
(GIBCO) at 37°C for 15 minutes and resuspended in 50µL of undiluted Growth Factor Reduced 
Matrigel (BD) and plated on 24 well multiwell plates (Corning). Each 50µL of Matrigel that consist 
around 10,000 cells per spheroid was cultured. The plate was then left in the incubator at 37°C for 
10 minutes for the Matrigel to set. Culture medium was then added to cover the Matrigel sphere.  
Spheres were cultured for 7 days and then analysed by immunocytochemistry. 
Green Fluorescent Protein (GFP) transfection of progenitor cell line and derivation of stably 
transfected lines. 
Qiagen Effectene was used for stable transfection. 5x10 of in vitro expanded progenitor cells were 
plated overnight. 1µg of vector with a puromycin resistant CAG-GFP was used to stably transfect 
cells with GFP, kindly provided by Dr Sally Lowell (University of Edinburgh). Transfected cells were 
cultured for 3 days and GFP expression was detected with fluorescence microscopy. Around 10 
percent of transfected cells expressed GFP after 4 days. The selection of stably transfected cells was 
carried with medium supplemented with 3 µg/ml puromycin for 14 days and colonies were picked 
with cloning rings and grown to generate clonally derived stably transfected lines. GFP expression of 
stably transfected lines were constantly monitored with fluorescent microscope. 
Enzyme-linked Immunosorbent assay (ELISA) detection of Albumin 
Conditioned medium from cultured cells was and stored at -80°C for further analysis. Stored medium 
was thawed at room temperature and tested for albumin concentration using Mouse Albumin ELISA 
Quantification Set following manufacturer’s protocol. Standard curve was generated using 
supplemented kits with different concentration of albumin. Absorbance at 450nm of was read using 
a spectrophotometer (SPECTROstar Omega). 
Analysis of cell area, roundness, and ratio of width to length 
Cell area, roundness, and ratio of width to length were analysed using the Operetta high content 
analysis system (PerkinElmer). Data analysis was performed using Columbus image data storage and 
analysis system. 
Karyotyping of cells 
Colcemid (Gibco) was added to the cultured cells for 18 hours. Cells were then trypsinised, washed 
with PBS and resuspended with 75mM KCL (Gibco) and incubated for 15 minutes at room 
temperature. Cells were then resuspended in fixatives (3:1 Methanol and Acetid Acid). Cells were 
washed and spread on glass slides. Slides were mounted with DAPI fluoromount (Southern Biotech). 
Number of chromosomes was counted using fluorescence microscopy.  
Real time PCR and gene expression analysis 
Genomic DNA (gDNA) was extracted from purified cell populations using whole liver using DNA 
Blood Mini Kit (Qiagen UK).  Total RNA was extracted from 30-50mg tissue samples previously stored 
in RNAlater at -80°C or cultured cells, using a combination of TRIzol™ reagent (Invitrogen) and 
Qiagen RNeasy Mini system according to manufacturer’s instructions (Qiagen, UK).  Reverse 
Transcription (including gDNA decontamination) and real time PCR was performed using reagents 
and primers (Quantifast and Quantitect respectively, Qiagen, UK) on a Roche Lightcycler 480.  
Mdm2flox integrity of gDNA was assessed using primers targeted to the floxed segment (Forward: 
ACGAGAAGCAGCAGCACATTG, Reverse: TTATAACCCACCACGCACAAGG) and a reference segment 
adjacent to Exon 3 (Forward: AACCTGGATTATCGCACAGTCG, Reverse: 
TCGCAGTGACCACTCTCTAATGC).  cDNA was prepared from purified cell populations using Data were 
analysed using the LightCycler system following normalization to the housekeeping gene 
peptidylprolyl isomerase A (Ppia).  All samples were run in triplicate.  
 
Statistical analysis 
Samples were randomized by a 'blinded' third party before being assessed separate 'blinded' 
assessor. Unblinding was performed immediately prior to final data analysis. Prism software 
(GraphPad Software, Inc) was used for all statistical analysis. Mean HPCs per x200 magnification field 
from 30 fields for each mouse were compared.  Data is presented as mean ± s.e.m. n refers to 
biological replicates. Normal distribution of data was determined using D‘Agostino and Pearson 
omnibus normality test. For parametric data, data significance was analysed using a two-tailed 
unpaired Students t-test. In cases where more than two groups were being compared, then a one-
way ANOVA was used. In instances where the n was too small to determine normal distribution or 
the data was non-parametric then a two-tailed Mann Whitney U-test was used. F tests were used to 
compare variances between groups.  
Reproducibility of experiments 
Routinely qPCR experiments were performed in technical triplicates when possible. For 
representative images whole liver lobes were examined histologically in multiple biological 
replicates. For figure 1b-f, k-l, 2a, b, d, e, I, j, Supplementary figures 2h, 3 a-c the images are 
representative for 30 mice in total over a 3-year period. For figure 2k, j, 4e, Supplementary figures 
3a-d, h, the images are representative for 6 mice. For figure 3a-f, 4a, c, f, 5a, the images are 
representative for 40 mice in total over a 1-year period. For figure 5f, g, 6c, d the images are 
representative for 7 mice. For figure 7g, i, m, Supplementary figures 4a, f, 5b-d the images are 
representative for 5 separate clonal cultures. For figure 7h the image is representative of 50 cells. 
For figure 7 a-d, k, Supplementary figure 1b, c the images are representative for 10 mice. For figure 8 
the images are representative for 23 mice. For Supplementary figures 2a-c, 4a the images are 
representative for 12 mice. For Supplementary figures 5a, 6a, 6b the images are representative for 7 
separate clonal cultures.  
In the cases of experiments in figures 1g-j, 2c, g, h, 5c, Supplementary figures 1a-c, 2a-h, 3e, 3f 
experiments were repeated twice. For figures 1g-j, 2c and Supplementary figures 2a-f these 
replicates consisted of repeated biological experiments with independent analysis, time points for 
analysis varied between experiments in 1h-j, 2c and Supplementary Figures 2e,f. For figures 2g, h 
and 5c and Supplementary Figures 2g, 3e, 3f, replicate experiments consisted of repeat analysis from 
biological samples from the level of RNA extraction. In the cases of experiments in figures 7e, f, 8a-h 
and Supplementary figures 4b, c, e, 5e, and 6c, flow cytometry and qPCR experiments were repeated 
for 3 times, transplantation experiments are shown as representative from 3 experiments . 
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